Perbedaan Keramika Indonesia Assosiasi Tbk. dan Organon Pharma Indonesia Tbk.: Keramika Indonesia Assosiasi Tbk. diperdagangkan di Rp21 (kapitalisasi pasar 313,51 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Keramika Indonesia Assosiasi Tbk. jauh lebih besar — sekitar 3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KIAS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 313,51 M | 104,4 M |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
KIA Group is one of the most diversified ceramic manufacturers in Indonesia, manufacturing Floor tiles (KSM), wall ties (KIA) and roof tiles (KKM). From their modest origins, a small ceramic tableware producer in the 1950s, KIA Group has to grown up to become Indonesias leading ceramic building material manufacturer. KIA Group received official recognition of its quality management system standard from SGS certification ISO 9002 no. Q4724 in 1995. In addition, KIA Group is in compliance with the World Bank Environmental and Social Policy Standard.
Selengkapnya di halaman KIAS →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →